JPRN-jRCT1041200007招募中4 期
Pathophysiological impacts of tafamidis on cardiac transthyretin amyloidosis - PICTA study
Fujimoto Naoki0 个研究点目标入组 20 人开始时间: 2020年4月28日最近更新:
试验速览
- 阶段
- 4 期
- 状态
- 招募中
- 发起方
- 入组人数
- 20
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 20age old 至 ot applicable（—）
- 性别
- All
入选标准
- •(1)heart failue patients with transthyretin amyloidosis
- •(2)patients with transthyretin amyloidosis confirmed by myocardial biopsy
- •(3)patients with LV thickness equal and/or greater than 12 mm
- •(4)patients wth age equal and/or greater than 20
- •(5)men and women
- •(6)patients with NYHA 1 to 3
- •(7) patients with LV hypertrophy (and diastolic dysfunction) caused by amyloid deposition
排除标准
- •(1) patients with severe valcular disease
- •(2) patients with NYHA4 heart failure
- •(3) patients with acute coronary syndrome
- •(4) patients with cardiogenic shock
- •(5) patients with severe liver failure
- •(6) patients with stage 5 kidney disease
- •(7) patients with infectious disease
- •(8) patients with a a life expectancy of less than 1 year
- •(9) pregnant patients
- •(10) patients who are unable to walk
研究者
相似试验
已完成
不适用
The effect of TNF blocking therapy on cardiac function in patients with active rheumatoid arthritisheart disease1001928010003816Rheumatoid arthritisNL-OMON44306Jan van Breemen Instituut50
尚未招募
Unknown
Monitoring the Efficacy of Tafamidis in ATTR Cardiac Amyloidosis by MRI-ECV: A Systematic Review and Meta-AnalysisTafamidis is a drug that improves the prognosis of transthyretin amyloid cardiomyopathy (ATTR-CM), but its primary effect is inhibition rather than improvement of amyloid deposition, making it difficult to assess therapeutic efficacy. The usefulness of monitoring treatment response using extracellular volume fractions (ECVs) with magnetic resonance imaging (MRI) has been reported, and we will perform a meta-analysis to evaluate the usefulness of this method.JPRN-UMIN000053556Yokohama City University
已完成
2 期
The effects of tumour necrosis factor antagonism (Etanercept) in patients with acute coronary syndromesAcute myocardial infarctionISRCTN97018444niversity of Edinburgh (UK)26
尚未招募
不适用
changes in heart function among patients who have undergone atrial septal defect(hole between the upper two chambers) closureCTRI/2020/06/026149Deaprtment of cardiology
招募中
不适用
the Role of cArdiac Inflammation, endoThelial Dysfunction, and FIbrosis in fabrY DiseaseFabry DiseaseNCT06776419Caroline Michaela Kistorp54